Aims Pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP). Rectal nonsteroidal anti-inflammatory drugs (rNSAIDs) administration is considered as standard of care to reduce the risk of post-ERCP pancreatitis. It has been suggested that aggressive hydration may further reduce this risk. Guidelines already recommend aggressive hydration. However, multicentre randomised trials studying the added value of aggressive hydration in patients receiving prophylactic rNSAIDs are lacking. We, therefore, performed a trial to investigate the combination of aggressive hydration and rNSAIDs.
MG Besselink合作论文数1HC van Santvoort合作论文数1W. van de Vrie合作论文数1MP Schwartz合作论文数1Alexander C Poen合作论文数1Mj Bruno合作论文数1Muhammed Hadithi合作论文数1Devica S. Umans合作论文数1Hester C Timmerhuis合作论文数1Robert C Verdonk合作论文数1Abha Bhalla合作论文数1
Wietske Kievit合作论文数1Venneman Niels G合作论文数1
van Wanrooij R L J合作论文数Department of Gastroenterology and Hepatology, VU University Medical Center1Thijs W J合作论文数1
Paul Fockens合作论文数Waikato Hospital, Health New Zealand;Amsterdam UMC;Vrije Universiteit Amsterdam;Faculty of Medicine, University of Amsterdam;PROCOLO - Center for Colon Examination1
H. (Harry) van Goor合作论文数Faculty of Medical Sciences, University of Groningen1P. Van Der Schaar合作论文数1
Aik Choon Tan合作论文数Department of Oncologic Sciences, University of South Florida;Huntsman Cancer Institute, Department of Oncological Sciences, University of Utah1
